Squarepoint Ops »

Black Diamond Therapeutics shares owned by Squarepoint Ops

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Squarepoint Ops from 13F filings

Historical chart of Squarepoint Ops investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by Squarepoint Ops consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by Squarepoint Ops

Quarter filed Position value Share count Share price at filing
2024-03-31 $869k 171k 5.07
2023-12-31 $407k 145k 2.81
2021-12-31 $100k 19k 5.36
2021-09-30 $170k 20k 8.46
2021-03-31 $1.5M 60k 24.26
2020-12-31 $975k 30k 32.04

More positions owned by Squarepoint Ops

Ishares Tr Msci Eafe Etf Call Option (EFA)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Ishares Tr Msci Emg Mkt Etf (EEM)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Microsoft Corporation Call Option (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Apple Call Option (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Meta Platforms Cl A Put Option (META)
Advanced Micro Devices Put Option (AMD)
Tesla Motors Put Option (TSLA)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Pdd Holdings Sponsored Ads Call Option (PDD)

View all positions for Squarepoint Ops

Top funds holding Black Diamond Therapeutics

Bellevue Group
T. Rowe Price Investment Management
NEA Management Company
RA Capital Management
Vanguard Group
Tang Capital Management
BlackRock
Artal Group
Laurion Capital Management
Kennedy Capital Management
Blue Owl Capital Holdings
Millennium Management
Boxer Capital
Susquehanna International
Geode Capital Management

View all funds holding Black Diamond Therapeutics